Neuland Laboratories Ltd Net Profit is INR 26.74 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Neuland Laboratories Ltd Quarter Net Profit is Up by 141 % from Last Year Quarter and Net Profit of INR 26.74 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 11.11 crores.
Quarterly Net Sales Year-on-Year
Neuland Laboratories Ltd Quarter Sale is up 20 % from Last Quarter. Sales of 245.39 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 203.84
Annual Sales & Net Earning
Neuland Laboratories Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 666.83 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 16.44 crores.
Neuland Laboratories Ltd Stock Information
| Sector | Pharmaceuticals |
| Industry | Pharmaceuticals – Indian – Bulk Drugs |
| About | Neuland is primarily an API manufacturer with a large bouquet of products that find acceptance with over 500+ generics and innovator companies largely in regulated markets (Europe, North America and Japan). Apart from APIs, the company focused on the custom manufacturing services (CMS) segment. This R&D focused business vertical partners with global innovator companies for developing intermediates and APIs for their novel molecules. In addition, it also includes manufacturing APIs for commercial molecules in line with customer specifications.( |
| Latest Qaurter EPS | 20.820040058916735 |
Neuland Laboratories Ltd Stock Analysis:
Get more Quarterly Earnings Results of companies
Get complete data on Neuland Laboratories Ltd
